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Abstract
We describe a sensitive high performance liquid chromatography (HPLC)-based method for
the determination of cholesterol in brain tissue. The method does not require the derivatiza-
tion of the analyte and uses separation and quantification by reversed-phase HPLC coupled
to UV detection. Lipids were methanol/chloroform extracted following the method of Bligh
and Dyer, and separated using isopropanol/acetonitrile/water (60/30/10, v/v/v) as mobile
phase. We observed lineal detection in a wide range of concentrations, from 62.5 to 2000
ng/μL, and were able to detect a significant increase in the brain cholesterol levels between
postnatal days 2 and 10 in C57BL6 mice. Based on our validation parameters, we consider
this analytical method a useful tool to assess free cholesterol in rodent brain samples and
cell cultures.
Introduction
Brain cholesterol represents 23% of the total body cholesterol and is relevant for brain struc-
ture and physiology. Optimal amounts of this sterol are essential to sustain important cellular
functions, like the permeability of the plasma membrane, the intramembrane diffusion of
receptors, the secretion of neurotransmitters, and the synthesis of steroids and myelin. Myelin
is a specialized membrane with a high percentage of lipids (*70%) compared to any other cell
membrane [1]. Cholesterol is particularly abundant in the myelin, representing approximately
30% of the total lipids. The high proportion of cholesterol and other lipids contribute to the
efficient and rapid propagation of the action potentials in neurons. The production of myelin
by the glial cells is absolutely dependent on the cholesterol biosynthesis, which involves more
than 20 enzymes that convert acetate into cholesterol [2, 3, 4, 5].
From the metabolic point of view, brain cholesterol is compartmentalized in two main
pools: the stable (*70%), found in the myelin membranes of the white matter, and the active
(*30%), present in the plasma and subcellular membranes of neurons and glial cells of the
gray matter. The concentration of cholesterol in the stable pool is high (*40 mg/g tissue) and
reflects the dense packing of multiple opposed lipid bilayers in the myelin sheath, while the
concentration in the active pool is lower (*8 mg/g tissue) [6].
Essentially all the brain cholesterol derives from the de novo synthesis, because this sterol
cannot cross the blood-brain barrier. In adult mammals, brain cholesterol is maintained
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almost constant because the rates of synthesis and catabolism are similar [6]. Cholesterol is
removed from the brain by catabolism to 24S-hydroxycholesterol, that crosses the blood brain
barrier and is transported via the circulation to the liver for further metabolism [7].
A relevant observation is that rodents, different to humans, myelinate essentially after birth
[8]. As a consequence, in the first two weeks of life, there is a significant increase in the mRNA
levels of the catabolic enzyme cholesterol 24-hydroxylase (CYP46A1), that is paralleled by
higher amounts of 24S-hydroxycholesterol in brain [9]. In addition, in the developing fetus,
after the closure of the blood-brain barrier, and in the very young animal, desmosterol levels
are high, indicating a rapid de novo synthesis of cholesterol [10].
Here, we developed a novel and reliable method to quantify cholesterol by HPLC with UV
detection, after lipid extraction with methanol/chloroform [11]. Because it has been demon-
strated that cholesterol rapidly increases in the mouse brain over the first days of postnatal life
due to the myelination process [8], we control our quantification method measuring the cho-
lesterol levels in the mouse brain at postnatal days 2 (P2) and 10 (P10). In agreement with pre-




C57BL6 newborn mice were obtained from females grown in our animal facility. The sacrifice
of the pups was done following the Guide for the Care and Use of Laboratory Animals (NRC,
USA) and local regulations of the ANMAT (Argentina). The experimental protocol was
approved by the Comité Institucional de Cuidado y Uso de Animales de Laboratorio
(CICUAL-BIOMED 005–2019).
2.2. Chemicals
Isopropanol and acetonitrile, used for the preparation of the mobile phase, were HPLC grade
(J.T. Baker). Ultrapure water was obtained using a Milli-Q filter system. Methanol and chloro-
form, utilized in the purification of lipids, were analytical grade. Cholesterol was from Sigma.
2.3. Samples and lipid extraction
Mouse brains were removed and placed in ice-cold HBSS without Ca2+/Mg2+. The whole tis-
sue was dissociated in 800 μL of acid saline solution (ASS, 0.9% NaCl in 15 mM HCl) using the
pipette tip. After the dissociation, 2 mL of methanol/1 mL of chloroform were added and the
sample was vortexed for 20 seconds. Then, 1 mL of chloroform/1 mL of ASS were added, and
the sample was vortexed, incubated for 10 minutes in ice and centrifuged at 200g for 5 minutes
at 4˚C. The upper phase was discharged and the lower phase was mixed with 2 mL of metha-
nol/1.8 mL of ASS. The sample was vortexed, incubated in ice for 10 minutes and centrifuged
at 200g for 5 minutes at 4˚C. Finally, the lower chloroform phase was dried out at 40˚C using a
speed-vac concentrator (Savant SPD121P, Thermo Scientific).
2.4. Instrumentation
The measurements were performed using a Dionex UltiMate 3000 System (Thermo Scientific)
equipped with autosampler and UV detector. The chloroform phase resulting from the metha-
nol/chloroform extraction was vacuum dried, resuspended in mobile phase and filtered
through a 45 μm PDVF filter. The autosampler was set to take 50 μL of this solution. The chro-
matographic separation was achieved using a Phenomenex Luna C18(2) column (150×4.6
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mm) packed with 5 μm silica particles. Instrument control, data acquisition and analysis were
achieved with the Chromeleon software (v7.2.6, Thermo Scientific).
2.5. Chromatographic separation
The chromatographic separation was performed using a mobile phase containing isopropa-
nol/acetonitrile/water (60/30/10, v/v/v), at a flow rate of 1 mL/min. The column temperature
was set at 28˚C and the monitoring wavelength at 205 nm. The identification of cholesterol
was done considering the full UV spectra and the retention time (RT). Cholesterol showed a
RT of 8.4 minutes. To quantify the amount of cholesterol the area under the curve (AUC) was
used.
2.6. Calibration curve
The highest standard (2 μg/μL) was prepared by solving 2 mg of cholesterol in 1 mL of ethanol.
This solution was then serially diluted in mobile phase to generate the different points of the
standard curve.
Results
3.1. Validation of the method
The complete validation of the method was done following widely accepted analytical criteria
[14, 15, 16]. The standard addition strategy was used to validate the cholesterol identification.
The cholesterol peaks were identified by comparison of their retention times with those of the
standards (Figs 1 and 2). The evidence that the shape and position of the cholesterol peaks
were not affected by the brain matrix suggested the absence of any apparent matrix effect.
This was confirmed by comparing the slopes of calibration curves made by spiking different
amounts of cholesterol either in mobile phase or matrix, which were 7.82 ± 1.06 and 8.06 ±
1.59, respectively. These slopes did not differ significantly (P = 0.80; Student’s t-test), confirm-
ing the absence of any matrix effect.
The limit of detection (LOD) was determined as the concentration that produced a detector
signal that could be clearly distinguished from the baseline (2 times larger than the baseline),
being in our case 15 ng/μL. The limit of quantification (LOQ) was determined injecting
Fig 1. Chromatogram of the cholesterol standard at 62.5 ng/μL (LOQ). The cholesterol peak (coral colored) shows a
characteristic RT of 8.4 minutes.
https://doi.org/10.1371/journal.pone.0228170.g001
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decreasing concentrations of the analyte until the signal to noise ratio was 9:1. For our method
the LOQ was 62.5 ng/μL.
The linearity of the method was tested using a 6-point calibration curve. At each concentra-
tion at least 3 replicates were assayed. The validation parameters of all fitted calibration curves
were satisfactory. The average calibration curve used to determine the amount of brain choles-
terol showed a R2 = 0.9981 (Fig 3).
Intra- and inter-day repeatability were estimated in triplicates with cholesterol standard
solutions of 62.5, 125, 250, 500 and 1000 ng/μL. All the relative standard deviations (RSD)
were below 5% (Table 1), indicating that the quantification method has very good precision.
Accuracy was determined by spiking brain samples with known amounts of cholesterol,
and expressed as the percentage of analyte recovery, calculated as follows:
Recovery ð%Þ ¼ ½ðmeasured amount   endogenous contentÞ=ðadded amountÞ� � 100
Our method showed a satisfactory analyte recovery of 86 ± 11% (n = 3).
In addition, to evaluate the robustness of the method we analyzed two variables that may
impact its performance: the monitoring wavelength and the column temperature. The choles-
terol RT stayed constant when we simultaneously monitored the signal at two different wave-
lengths, 205 and 208 nm. We decided to set 205 nm as the optimal wavelength because the
obtained AUC was slightly higher than the AUC at 208 nm. Setting the column temperature
either at 22˚C or 28˚C did not have any impact on the RT or AUC.
3.2. Application of the method to brain samples
After the analytical validation of the method, we measured the cholesterol levels in brains of
C57BL6 mice at postnatal days 2 (P2) and 10 (P10). In this interval of the postnatal life, the
amount of cholesterol increased from 3.7 ± 0.4 to 6.2 ± 0.7 μg/mg of wet tissue (p< 0.05, Stu-
dent’s t-test; Fig 4). This 68% increase is in agreement with previous findings showing a higher
cholesterol biosynthesis after birth in mouse and rats [6].
Fig 2. Representative chromatogram showing the cholesterol detection in brain tissue (coral peak). The dried
lipids obtained after the methanol/chloroform purification were solved in 1 mL of mobile phase and 50 μL of this
solution were injected for analysis.
https://doi.org/10.1371/journal.pone.0228170.g002
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Discussion
In mice, the levels of brain cholesterol progressively increase from birth to 3 months of age,
reaching approximately 150 micrograms per milligram of wet tissue (see Table 2). In the pres-
ent work, using HPLC with UV detection, we report similar cholesterol amounts in the early
postnatal mouse brain (0–10 micrograms per milligram of wet tissue). In addition, we found a
significant increase in the levels of brain cholesterol in 10 days-old mice, compared to 2 days-
old mice, most likely due to the higher cholesterol biosynthesis required for myelin formation
in this early postnatal period.
The detection of brain cholesterol changes has relevance to understand the neurobiology of
several disorders associated to dysfunctions in the homeostasis of this lipid [17, 18, 19, 20, 21].
Traditionally, cholesterol has been quantified in different brain preparations by the cholesterol
oxidase method, coupled to colorimetric or fluorometric detection, LC/MS or GC/MS (see
Table 3). Here, we describe a different way to analyze free cholesterol in brain samples from
which lipids are extracted using methanol/chloroform [11]. Compared with a previously
reported method [22], we found out higher signals monitoring the absorbance at 205 nm
instead of 200 nm. Another difference is that we do not perform an Abell-Kendall saponifica-
tion of the sample, followed by lipid extraction with petroleum ether or hexane. Instead, we
use methanol and chloroform for lipid extraction, which can be manipulated and disposed in
an easier way than petroleum ether or hexane. In addition, we were able to detect low amounts
Fig 3. Calibration curve used to determine the amount of cholesterol in the experimental samples. The linear
regression showed very good correlation (y = 7.89 x + 13.47; R2 = 0.9981).
https://doi.org/10.1371/journal.pone.0228170.g003
Table 1. Intra- and inter-day precision of the cholesterol determination. The relative standard deviation (RSD) at
five concentration levels of the cholesterol standard is shown.
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of cholesterol in different cell lines in culture, indicating that our method is also suitable to
quantify free cholesterol in small pieces of tissue, like mouse brain structures.
Although GC or LC separation associated to MS detection remain the most sensitive meth-
odologies for cholesterol quantification in tissues and cultured cells [23], the here reported
HPLC method with UV detection represents a reliable alternative to measure cholesterol in
biological samples.
Author Contributions
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Fig 4. Cholesterol concentrations in whole brains of C57BL6 mice at postnatal days 2 (P2) and 10 (P10). Data are
expressed as μg of cholesterol/mg of wet tissue (μg/mg wt). Bars represent mean ± SEM (n = 3); � p< 0.05, Student’s t-
test.
https://doi.org/10.1371/journal.pone.0228170.g004
Table 2. Comparison of brain cholesterol levels determined by different methodologies. The reported cholesterol concentrations in early life are similar to the
amounts measured by HPLC with UV detection in this work.
Report Mouse age Quantification method Measured cholesterol (μg/mg wet tissue)
Marcos J. et al. [12] 1 day GC-MS 2.5
Marcos J. et al. [12] 14 days GC-MS 6
Meljon A. et al. [13] 1 day LC-MS 2.2
Meljon A. et al. [13] 15 weeks LC-MS 16
Lu F. et al. [24] 9 days Enzymatic 8.5
Nunes V.S. et al. [25] 12 weeks GC-MS 120
https://doi.org/10.1371/journal.pone.0228170.t002
Table 3. Different analytical approaches commonly used to determine cholesterol in biological samples. The type
of detection and the limit of quantification (LOQ) of each methodology are shown.
Method Detection LOQ (ng/μL)
Enzymatic/colorimetric [26] 500 nm (quinoneimine) 250
Enzymatic/fluorometric [27] 585 nm (resorufin) 0.1
HPLC-UV [present work] 205 nm (cholesterol) 62.5
LC-MS m/z < 50
GC-MS m/z < 50
https://doi.org/10.1371/journal.pone.0228170.t003
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